[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema]. [electronic resource]
Producer: 20110218Description: 701-11 p. digitalISSN:- 1439-3999
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Aptamers, Nucleotide -- administration & dosage
- Bevacizumab
- Blood-Retinal Barrier -- drug effects
- Capillary Permeability -- drug effects
- Clinical Trials as Topic
- Combined Modality Therapy
- Diabetic Retinopathy -- classification
- Fluorescein Angiography
- Humans
- Intravitreal Injections
- Laser Coagulation -- adverse effects
- Macular Edema -- classification
- Middle Aged
- Off-Label Use
- Ranibizumab
- Receptors, Vascular Endothelial Growth Factor
- Recombinant Fusion Proteins -- administration & dosage
- Retinoscopy
- Triamcinolone -- administration & dosage
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.